2003
DOI: 10.1176/jnp.15.3.317
|View full text |Cite
|
Sign up to set email alerts
|

Neuropsychological Effects of Chronic Methamphetamine Use on Neurotransmitters and Cognition: A Review

Abstract: Methamphetamine use is on the rise, with an imminent upsurge of abuse and dependence reported across the United States. Currently, preliminary evidence suggests that methamphetamine dependence may cause long-term neural damage in humans, with concomitant deleterious effects on cognitive processes such as memory and attention. This selective review provides an outline and synthesis of studies that assess the neurotoxic mechanisms of methamphetamine, as well as those that evaluate the cognitive sequelae of metha… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

5
131
0
1

Year Published

2004
2004
2018
2018

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 270 publications
(137 citation statements)
references
References 70 publications
5
131
0
1
Order By: Relevance
“…The means by which METH leads to CNS damage with cognitive and psychiatric disorders (Cadet et al, 2003;Nordahl et al, 2003) the degree of potential neurochemical and functional recovery from damage (Volkow et al, 2001;Wang et al, 2004) and its interactions with other pathogenic challenges, such as HIV infection (Rippeth et al, 2004) are still relatively unknown. The use of this experimental animal model will enable the study of the chronic effects of METH, as well as therapeutic means for their amelioration.…”
Section: Discussionmentioning
confidence: 99%
“…The means by which METH leads to CNS damage with cognitive and psychiatric disorders (Cadet et al, 2003;Nordahl et al, 2003) the degree of potential neurochemical and functional recovery from damage (Volkow et al, 2001;Wang et al, 2004) and its interactions with other pathogenic challenges, such as HIV infection (Rippeth et al, 2004) are still relatively unknown. The use of this experimental animal model will enable the study of the chronic effects of METH, as well as therapeutic means for their amelioration.…”
Section: Discussionmentioning
confidence: 99%
“…Dopamine antagonists (like haloperidol) that affect the meso-striatal dopamine system slow down the clock rate in healthy subjects (Rammsayer, 1989; whereas timing behavior in animals and humans under the acute influence of METH can be interpreted as the result of speeding up the clock rate (Buhusi and Meck, 2002;Cevik, 2003;Mohs et al, 1980). Functional neuroimaging and neuropsychological studies show that chronic stimulant users have significant brain activation changes in frontostriatal regions that are associated with impairments in attention, working memory, and decision making (Fein et al, 2002: McKetin andMattick, 1997;Nordahl et al, 2003;O'Mally et al, 1992;Paulus et al 2003;Salo et al, 2005). Stimulant-using individuals and stimulant-dependent individuals (SDI) show fundamental cognitive deficits and increased impulsivity when making decisions (Leland and Paulus, 2005;Fillmore and Rush, 2002;Paulus et al, 2002).…”
Section: Introductionmentioning
confidence: 99%
“…Several lines of evidence demonstrated that MAP dependence may cause long-term neural damage in humans, with concomitant deleterious effects on cognitive processes such as memory and attention (Nordahl et al, 2003), suggesting the possible role of BDNF secretion in the memory deficits of MAP abusers. The other SNP frequently analyzed is 132C>T in the noncoding region of exon V (GENBANK: AF411339; at position 53620).…”
Section: Introductionmentioning
confidence: 99%